SPERO
"SPERO" is a word and design mark owned by Spero Therapeutics, Inc., filed at the USPTO on September 24, 2026. It is under examination and covers classes 5 and 42.
- Status
- Under examination
- Since September 24, 2026
- Filed
- September 24, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50127853
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 2 classes
Who owns SPERO
The owner and representative on file with the office.
Owner
Spero Therapeutics, Inc.
Cambridge, United States
Representative
Jonathan M. Gelchinsky
Pierce Atwood LLP
What the mark covers
The products and services SPERO is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of immunological diseases and disorders; Pharmaceutical preparations for the treatment of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of rheumatological diseases and disorders; Pharmaceutical preparations for the treatment of immune-mediated diseases and disorders
Pharmaceutical research services; Pharmaceutical drug development services
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About SPERO
Who owns the trademark "SPERO"?
The USPTO trademark "SPERO" (application 50127853) is owned by Spero Therapeutics, Inc.
What is the status of "SPERO"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull SPERO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a0d8b6-3648-732d-b4e8-97f9b21e10b6
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a0d8b6-3648-732d-b4e8-97f9b21e10b6",
"object": "trademark",
"mark_text": "SPERO",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50127853",
"filing_date": "2026-09-24",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "Spero Therapeutics, Inc.",
"entity_id": null
}
]
}